Savella in Treatment for Provoked Vestibulodynia

PHASE3CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
VestibulodyniaVulvodynia
Interventions
DRUG

Milnacipran

6-week titration period starting at 12.5mg daily and moving up to 200mg daily (or maximum tolerated dose) for 12 weeks - total treatment period is 18 weeks

Trial Locations (1)

38138

Women's Health Specialists, PLLC, Germantown

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

University of Tennessee

OTHER